Export 1630 results:
Autore Titolo Tipo [ Anno(Asc)]
Filtri: First Letter Of Last Name è B  [Clear All Filters]
2010
Bua J, Marchetti F, Faleschini E, Ventura A, Bussani R. Hepatic glycogenosis in an adolescent with diabetes. J Pediatr 2010;157(6):1042.
Bua J, Marchetti F, Faleschini E, Ventura A, Bussani R. Hepatic glycogenosis in an adolescent with diabetes. J Pediatr 2010;157(6):1042.
Castagnola E, Rossi MR, Cesaro S, Livadiotti S, Giacchino M, Zanazzo G, Fioredda F, Beretta C, Ciocchello F, Carli M, Putti MCaterina, Pansini V, Berger M, Licciardello M, Farina S, Caviglia I, Haupt R. Incidence of bacteremias and invasive mycoses in children with acute non-lymphoblastic leukemia: results from a multi-center Italian study. Pediatr Blood Cancer 2010;55(6):1103-7.
Castagnola E, Rossi MR, Cesaro S, Livadiotti S, Giacchino M, Zanazzo G, Fioredda F, Beretta C, Ciocchello F, Carli M, Putti MCaterina, Pansini V, Berger M, Licciardello M, Farina S, Caviglia I, Haupt R. Incidence of bacteremias and invasive mycoses in children with acute non-lymphoblastic leukemia: results from a multi-center Italian study. Pediatr Blood Cancer 2010;55(6):1103-7.
Bembich S, Lanzara C, Clarici A, Demarini S, Tepper BJ, Gasparini P, Grasso DL. Individual differences in prefrontal cortex activity during perception of bitter taste using fNIRS methodology. Chem Senses 2010;35(9):801-12.
Biarnés X, Marchiori A, Giorgetti A, Lanzara C, Gasparini P, Carloni P, Born S, Brockhoff A, Behrens M, Meyerhof W. Insights into the binding of Phenyltiocarbamide (PTC) agonist to its target human TAS2R38 bitter receptor. PLoS One 2010;5(8):e12394.
Biarnés X, Marchiori A, Giorgetti A, Lanzara C, Gasparini P, Carloni P, Born S, Brockhoff A, Behrens M, Meyerhof W. Insights into the binding of Phenyltiocarbamide (PTC) agonist to its target human TAS2R38 bitter receptor. PLoS One 2010;5(8):e12394.
Biarnés X, Marchiori A, Giorgetti A, Lanzara C, Gasparini P, Carloni P, Born S, Brockhoff A, Behrens M, Meyerhof W. Insights into the binding of Phenyltiocarbamide (PTC) agonist to its target human TAS2R38 bitter receptor. PLoS One 2010;5(8):e12394.
Biarnés X, Marchiori A, Giorgetti A, Lanzara C, Gasparini P, Carloni P, Born S, Brockhoff A, Behrens M, Meyerhof W. Insights into the binding of Phenyltiocarbamide (PTC) agonist to its target human TAS2R38 bitter receptor. PLoS One 2010;5(8):e12394.
Comar M, Zanotta N, Bovenzi M, Campello C. JCV/BKV and SV40 viral load in lymphoid tissues of young immunocompetent children from an area of north-east Italy. J Med Virol 2010;82(7):1236-40.
Bembi B, Pisa FEdith, Confalonieri M, Ciana G, Fiumara A, Parini R, Rigoldi M, Moglia A, Costa A, Carlucci A, Danesino C, Pittis MGabriela, Dardis A, Ravaglia S. Long-term observational, non-randomized study of enzyme replacement therapy in late-onset glycogenosis type II. J Inherit Metab Dis 2010;33(6):727-35.
Bulla R, De Seta F, Radillo O, Agostinis C, Durigutto P, Pellis V, De Santo D, Crovella S, Tedesco F. Mannose-binding lectin is produced by vaginal epithelial cells and its level in the vaginal fluid is influenced by progesterone. Mol Immunol 2010;48(1-3):281-6.

Amministrazione Trasparente